 | • レポートコード：QFJ1-4397 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、炎症性腸疾患体外診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アッセイ/バイオマーカー、アナライザー）、用途別市場規模（診断研究所、病院、研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・炎症性腸疾患体外診断の市場動向 ・企業の競争状況、市場シェア ・炎症性腸疾患体外診断の種類別市場規模と予測2016-2027（アッセイ/バイオマーカー、アナライザー） ・炎症性腸疾患体外診断の用途別市場規模と予測2016-2027（診断研究所、病院、研究機関） ・炎症性腸疾患体外診断の北米市場規模2016-2027（アメリカ、カナダ） ・炎症性腸疾患体外診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・炎症性腸疾患体外診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・炎症性腸疾患体外診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・炎症性腸疾患体外診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（DiaSorin S.p.A、F. Hoffmann-La Roche Ltd、Siemens Healthineers AG、Abbott、Quidel Corporation、American Laboratory Products Company (ALPCO)、Certest Biotec SL.、Biosystems S.A.） ・結論 |
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual .Common symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.
Market Analysis and Insights: Global In-vitro Inflammatory Bowel Disease Diagnostic Market
The global In-vitro Inflammatory Bowel Disease Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-vitro Inflammatory Bowel Disease Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-vitro Inflammatory Bowel Disease Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-vitro Inflammatory Bowel Disease Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-vitro Inflammatory Bowel Disease Diagnostic market.
Global In-vitro Inflammatory Bowel Disease Diagnostic Scope and Market Size
In-vitro Inflammatory Bowel Disease Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-vitro Inflammatory Bowel Disease Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Assays/Biomarker
Analyzers
Segment by Application
Diagnostic Laboratories
Hospitals
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Assays/Biomarker
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Perspective (2016-2027)
2.2 In-vitro Inflammatory Bowel Disease Diagnostic Growth Trends by Regions
2.2.1 In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 In-vitro Inflammatory Bowel Disease Diagnostic Industry Dynamic
2.3.1 In-vitro Inflammatory Bowel Disease Diagnostic Market Trends
2.3.2 In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
2.3.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
2.3.4 In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue
3.1.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue (2016-2021)
3.1.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-vitro Inflammatory Bowel Disease Diagnostic Revenue
3.4 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio
3.4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2020
3.5 In-vitro Inflammatory Bowel Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players In-vitro Inflammatory Bowel Disease Diagnostic Product Solution and Service
3.7 Date of Enter into In-vitro Inflammatory Bowel Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Type
4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2022-2027)
5 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Application
5.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
6.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
6.2.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
6.2.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
6.2.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
6.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
6.3.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
6.3.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
6.3.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
6.4 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
6.4.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021)
6.4.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
7.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
7.2.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
7.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
7.3.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
7.4 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
7.4.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
8.2.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
8.3.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region
8.4.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
9.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
9.2.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
9.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
9.3.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
9.4 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
9.4.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
10.2.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
10.3.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
10.4.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 DiaSorin S.p.A
11.1.1 DiaSorin S.p.A Company Details
11.1.2 DiaSorin S.p.A Business Overview
11.1.3 DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.1.4 DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.1.5 DiaSorin S.p.A Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Siemens Healthineers AG
11.3.1 Siemens Healthineers AG Company Details
11.3.2 Siemens Healthineers AG Business Overview
11.3.3 Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.3.4 Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.3.5 Siemens Healthineers AG Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.4.4 Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Quidel Corporation
11.5.1 Quidel Corporation Company Details
11.5.2 Quidel Corporation Business Overview
11.5.3 Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.5.4 Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.5.5 Quidel Corporation Recent Development
11.6 American Laboratory Products Company (ALPCO)
11.6.1 American Laboratory Products Company (ALPCO) Company Details
11.6.2 American Laboratory Products Company (ALPCO) Business Overview
11.6.3 American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.6.4 American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.6.5 American Laboratory Products Company (ALPCO) Recent Development
11.7 Certest Biotec SL.
11.7.1 Certest Biotec SL. Company Details
11.7.2 Certest Biotec SL. Business Overview
11.7.3 Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.7.4 Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.7.5 Certest Biotec SL. Recent Development
11.8 Biosystems S.A.
11.8.1 Biosystems S.A. Company Details
11.8.2 Biosystems S.A. Business Overview
11.8.3 Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.8.4 Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.8.5 Biosystems S.A. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Assays/Biomarker
Table 3. Key Players of Analyzers
Table 4. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Regions (2016-2021)
Table 8. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Regions (2022-2027)
Table 10. In-vitro Inflammatory Bowel Disease Diagnostic Market Trends
Table 11. In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
Table 12. In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
Table 13. In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
Table 14. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Players (2016-2021)
Table 16. Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Inflammatory Bowel Disease Diagnostic as of 2020)
Table 17. Ranking of Global Top In-vitro Inflammatory Bowel Disease Diagnostic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by In-vitro Inflammatory Bowel Disease Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In-vitro Inflammatory Bowel Disease Diagnostic Product Solution and Service
Table 21. Date of Enter into In-vitro Inflammatory Bowel Disease Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2016-2021)
Table 25. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Application (2016-2021)
Table 29. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 61. DiaSorin S.p.A Company Details
Table 62. DiaSorin S.p.A Business Overview
Table 63. DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 64. DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 65. DiaSorin S.p.A Recent Development
Table 66. F. Hoffmann-La Roche Ltd Company Details
Table 67. F. Hoffmann-La Roche Ltd Business Overview
Table 68. F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 69. F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 70. F. Hoffmann-La Roche Ltd Recent Development
Table 71. Siemens Healthineers AG Company Details
Table 72. Siemens Healthineers AG Business Overview
Table 73. Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 74. Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 75. Siemens Healthineers AG Recent Development
Table 76. Abbott Company Details
Table 77. Abbott Business Overview
Table 78. Abbott In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 79. Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 80. Abbott Recent Development
Table 81. Quidel Corporation Company Details
Table 82. Quidel Corporation Business Overview
Table 83. Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 84. Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 85. Quidel Corporation Recent Development
Table 86. American Laboratory Products Company (ALPCO) Company Details
Table 87. American Laboratory Products Company (ALPCO) Business Overview
Table 88. American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 89. American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 90. American Laboratory Products Company (ALPCO) Recent Development
Table 91. Certest Biotec SL. Company Details
Table 92. Certest Biotec SL. Business Overview
Table 93. Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 94. Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 95. Certest Biotec SL. Recent Development
Table 96. Biosystems S.A. Company Details
Table 97. Biosystems S.A. Business Overview
Table 98. Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 99. Biosystems S.A. Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Assays/Biomarker Features
Figure 3. Analyzers Features
Figure 4. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application: 2020 VS 2027
Figure 5. Diagnostic Laboratories Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. In-vitro Inflammatory Bowel Disease Diagnostic Report Years Considered
Figure 9. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Regions: 2020 VS 2027
Figure 12. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Regions (2022-2027)
Figure 13. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Players in 2020
Figure 14. Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Inflammatory Bowel Disease Diagnostic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2020
Figure 16. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2016-2021)
Figure 17. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2022-2027)
Figure 18. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2016-2027)
Figure 20. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2016-2027)
Figure 21. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2016-2027)
Figure 22. United States In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2016-2027)
Figure 26. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2016-2027)
Figure 27. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2016-2027)
Figure 28. Germany In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2016-2027)
Figure 38. China In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2016-2027)
Figure 46. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2016-2027)
Figure 47. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2016-2027)
Figure 48. Mexico In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2016-2027)
Figure 54. Turkey In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. DiaSorin S.p.A Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
Figure 58. F. Hoffmann-La Roche Ltd Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
Figure 59. Siemens Healthineers AG Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
Figure 60. Abbott Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
Figure 61. Quidel Corporation Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
Figure 62. American Laboratory Products Company (ALPCO) Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
Figure 63. Certest Biotec SL. Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
Figure 64. Biosystems S.A. Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…- 炎症性腸疾患療法のグローバル市場：規模・現状・予測2019-2025 Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
- 炎症性腸疾患療法のグローバル市場：規模・現状・予測2019-2025 Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
- 炎症性腸疾患療法のグローバル市場：規模・現状・予測2019-2025 Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
- 炎症性腸疾患治療のグローバル市場調査 2019年 The global Inflammatory Bowel Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Inflammatory Bowel Disease Treatment volume and value at global level, regional level and company leve…